Pesta M - Search Results

1

Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma.

Kulda V, Polivka J, Svaton M, Vanecek T, Buresova M, Houfkova K, Bagheri MS, Knizkova T, Vankova B, Windrichova J, Macan P, Babuska V, Pesta M. Kulda V, et al. Among authors: pesta m. Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):404-411. doi: 10.21873/cgp.20392. Cancer Genomics Proteomics. 2023. PMID: 37400146 Free PMC article.

2

The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness.

Mayer O Jr, Filipovský J, Pesta M, Cífková R, Dolejšová M, Simon J. Mayer O Jr, et al. Among authors: pesta m. Physiol Res. 2010;59(4):529-536. doi: 10.33549/physiolres.931791. Epub 2009 Nov 20. Physiol Res. 2010. PMID: 19929133 Free article.

3

[Vitamin D in relation to head and neck cancer].

Kalfeřt D, Ludvíková M, Pešta M, Topolčan O. Kalfeřt D, et al. Among authors: pesta m. Vnitr Lek. 2014 Jan;60(1):51-8. Vnitr Lek. 2014. PMID: 24564776 Review. Czech.

4

[New aspects of tumor pathobiology].

Ludvíková M, Pesta M, Holubec L Jr, Kalfert D. Ludvíková M, et al. Among authors: pesta m. Cesk Patol. 2009 Oct;45(4):94-9. Cesk Patol. 2009. PMID: 20301835 Review. Czech.

5

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.

Keil R, Wasserbauer M, Zádorová Z, Hajer J, Drastich P, Wohl P, Beneš M, Bojková M, Svoboda P, Konečný M, Falt P, Vaňásek T, Pešta M, Pešek F, Bouchner L, Koželuhová J, Novotný A, Bartůsková L, Špičák J. Keil R, et al. Among authors: pesta m. Scand J Gastroenterol. 2016 Sep;51(9):1062-8. doi: 10.3109/00365521.2016.1149883. Epub 2016 Mar 22. Scand J Gastroenterol. 2016. PMID: 27002981 Free PMC article.

6

Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.

Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V. Safranek J, et al. Among authors: pesta m. Anticancer Res. 2009 Jul;29(7):2513-7. Anticancer Res. 2009. PMID: 19596921 Free article.

7

Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC.

Pesta M, Kulda V, Topolcan O, Safranek J, Vrzalova J, Cerny R, Holubec L. Pesta M, et al. Anticancer Res. 2009 Nov;29(11):4535-9. Anticancer Res. 2009. PMID: 20032402 Free article.

8

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.

Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L Jr, Cerny R. Kulda V, et al. Among authors: pesta m. Cancer Genet Cytogenet. 2010 Jul 15;200(2):154-60. doi: 10.1016/j.cancergencyto.2010.04.015. Cancer Genet Cytogenet. 2010. PMID: 20620599

9

Importance of miR-20a expression in prostate cancer tissue.

Pesta M, Klecka J, Kulda V, Topolcan O, Hora M, Eret V, Ludvikova M, Babjuk M, Novak K, Stolz J, Holubec L. Pesta M, et al. Anticancer Res. 2010 Sep;30(9):3579-83. Anticancer Res. 2010. PMID: 20944140

10

Characterization of P19 cells during retinoic acid induced differentiation.

Babuška V, Kulda V, Houdek Z, Pešta M, Cendelín J, Zech N, Pacherník J, Vožeh F, Uher P, Králíčková M. Babuška V, et al. Among authors: pesta m. Prague Med Rep. 2010;111(4):289-99. Prague Med Rep. 2010. PMID: 21189168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page